- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02112409
Intraoperative Cell Salvage and Hemodilution Technique in Scoliosis Surgery
Autologous Blood Transfusion Technique in Idiopathic Scoliosis Surgery - a Comparison Between Intraoperative Cell Salvage With Hemodilution Techniques Versus Cell Salvage Technique Alone
Surgical correction of scoliosis with instrumentation carries significant blood loss and needs for blood transfusion with its inherent risk and cost. In recent years, there is an increased interest in utilizing autologous blood as part of perioperative blood conservation strategy.
The foremost mechanical methods of perioperative conservation of red blood cells including intraoperative cell salvage (ICS) and acute normovolemic hemodilution (ANH). They should be considered in all cases where significant blood loss (>1000 ml) or >20% estimated blood volume is expected, in patients with multiple antibodies or rare blood types and those who refuse allogenic blood products.
Literature search has revealed that both cell salvage method and ANH utilized in elective surgeries are capable of minimizing allogenic blood transfusion respectively. Surgeries which are of significant relevance are aortic surgery, cardiac surgery and arthroplasty orthopaedic surgery. Combining the above two techniques such as in ATIS trial 2002 also shows that it is safe and significantly reduced allogenic blood requirements in aortic surgery. However till date, there is still lack of strong evidence that autologous blood transfusion technique is beneficial for scoliosis surgery in reducing allogenic blood transfusion.
Hypothesis:
The investigators hypothesize that the addition of ANH to ICS would confer additional benefit than using cell saver alone. By combining cell saver with hemodilution technique, the difference between pre-operative and post-operative Hemoglobin level will be smaller than using cell saver technique alone, hence minimizing the variation in perioperative Hemoglobin level - a predictor of allogenic blood transfusion.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients who meet the inclusion criteria are enrolled in the study. They are assigned to 2 arms of study group using concealed allocation method. A computerized random-number generator will be used to formulate an allocation schedule. Group A will receive cell salvage and acute normovolemic hemodilution during operation; Group B will only receive cell salvage as sole autologous transfusion strategy.
Members of the research team should attend all operations and record all data. Anaesthetic technique including drugs usage, equipments and monitoring devices are standardized as per protocol. Intraoperative fluid management is recorded in details.
All patients enrolled in the study (group A and B) underwent cell saver technique during surgery using Cell Saver® 5+ autologous blood recovery system-Haemonetics devices. All patients allocated in group A also received additional acute normovolemic hemodilution (ANH) after induction of anaesthesia. As a standardization measure, before starting skin incision, 500ml blood will be collected from the radial artery to a standard blood collection bag and stored as CPD blood at ambient temperature. Simultaneously, 500ml Voluven® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride) will be infused through a peripheral vein.
All autologous blood will be re-infused back to patient at surgery completion or within 6 hours of withdrawal. Autologous blood will be given to patient during surgery at any point if there are 30% or more body blood volume loss.
Allogenic blood will be administered when the intraoperative hemoglobin concentration fell below 8g/dl despite completion of autologous blood transfusion or when autologous blood not available; adequate volume correction by mean of collected autologous blood and crystalloid fluid administration, or when presence of ischemic electrocardiogram changes (2mV ST segment elevation or depression on 3 leads monitoring); persistent hypotension or tachycardia >20% from baseline.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kuala Lumpur, Malaysia, 59100
- University Malaya Medical Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elective single stage posterior spinal fusion for scoliosis corrective surgery
- Diagnosis of idiopathic scoliosis
- Age >10 and <25
- ASA I or II
- Preoperative Hemoglobin > 10 g/dL
- Preoperative Platelet > 150,000/L
- Clinically fit for surgery
- Written informed consent
Exclusion Criteria:
- Patient's refusal of homologous blood
- Hematological disorder rendering either transfusion technique inappropriate
- Patients who received anticoagulants and antiplatelets perioperatively
- Severe cardiac disease (Aortic stenosis or cardiac ejection fraction <40%; Myocardial infarction in the previous 6 Months; Myocardial ischaemia on resting Electrocardiogram)
- Severe pulmonary disease (FEV1 50% predicted, PaO2 9 kpa on air)
- Preoperative creatinine >200 mmol/L
- AST >100 IU/L
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: cell salvage and hemodilution technique
cell salvage technique throughout scoliosis corrective surgery; Acute normovolemic hemodilution technique commenced after induction of anaesthesia and prior the starting of surgery.
|
blood from the surgical field is collected, anti-coagulated, filtered, centrifuged, washed and re-suspended in saline to produce autologous blood with a resultant haematocrit of 50-80% for transfusion back to the patient using specific cell saver device
Other Names:
Removal of 500ml whole blood from the patient after induction of anesthesia, with restoration of blood volume with acellular fluid using equivolume of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (voluven) to maintain isovolemia
Other Names:
|
|
Active Comparator: cell salvage
cell salvage technique throughout scoliosis corrective surgery
|
blood from the surgical field is collected, anti-coagulated, filtered, centrifuged, washed and re-suspended in saline to produce autologous blood with a resultant haematocrit of 50-80% for transfusion back to the patient using specific cell saver device
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in pre-operative and post-operative hemoglobin level
Time Frame: at 0 hour and 24 hour post-operation
|
Laboratory testing for hemoglobin level will be carry out at 0 hour and 24 hour post-operation.
|
at 0 hour and 24 hour post-operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perioperative requirement of allogenic blood transfusion
Time Frame: one week post-operation
|
participants (patients) will be followed for the duration of hospital stay, an expected average of one week.
|
one week post-operation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: M Shahnaz Hasan, MBBS, MAnaes, University of Malaya
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEC 201312-0621
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Idiopathic Scoliosis
-
Lahore University of Biological and Applied SciencesGhurki Trust and Teaching HospitalNot yet recruitingScoliosis Idiopathic | Idiopathic Adolescent ScoliosisPakistan
-
Uppsala UniversityUniversity of Oslo; Linkoeping University; Örebro University, Sweden; Skane University... and other collaboratorsNot yet recruitingIdiopathic Adolescent Scoliosis | Idiopathic Juvenile ScoliosisSweden
-
Hasan Kalyoncu UniversityNot yet recruitingScoliosis Idiopathic | Scoliosis Idiopathic Adolescent | Caregiver AnxietyTurkey (Türkiye)
-
National Scoliosis CenterCompletedAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular Scoliosis | Juvenile Idiopathic Scoliosis | Infantile Idiopathic Scoliosis | Ealy Onset ScoliosisUnited States
-
Istinye UniversityRecruitingScoliosis Idiopathic Adolescent Treatment | Scoliosis Idiopathic AdolescentTurkey (Türkiye)
-
Hasan Kalyoncu UniversityThe Scientific and Technological Research Council of TurkeyRecruitingScoliosis Idiopathic Adolescent Treatment | Scoliosis Idiopathic AdolescentTurkey
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingScoliosis Idiopathic AdolescentFrance
-
Beni-Suef UniversityCompletedAdolescent Idiopathic Scoliosis (AIS)Egypt
-
Istituto Scientifico Italiano Colonna VertebraleActive, not recruitingAdolescent Idiopathic Scoliosis (AIS)Italy
-
University College, LondonShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University and other collaboratorsNot yet recruitingAdolescent Idiopathic Scoliosis (AIS)
Clinical Trials on cell salvage technique
-
Insel Gruppe AG, University Hospital BernUniversity of Zurich; University Hospital, GenevaRecruiting
-
Belfast Health and Social Care TrustUnknownBlood Conservation in Adult Cardiac Surgery, What is the Way Forward in Today's Practice? (CONSERVE)Blood Transfusion | Adult Cardiac SurgeryUnited Kingdom
-
Eduardo SchifferUniversity Hospital, Geneva; Insel Gruppe AG, University Hospital BernNot yet recruitingLiver Transplant | Hemorrhage, SurgicalSwitzerland
-
Shanghai General Hospital, Shanghai Jiao Tong University...Ruijin Hospital; Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao... and other collaboratorsRecruitingPeripheral T Cell LymphomaChina
-
University of LiegeCompletedRevision of Total Hip ArthroplastyBelgium
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed or Refractory Acute Myeloid LeukemiaChina
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Regina Elena Cancer InstituteAlessia Farneti; Adriana Faiella; Marta Bottero; Pasqualina D'Urso; Valeria Landoni; Antonella Soriani and other collaboratorsRecruitingProstatic NeoplasmItaly
-
The HIV Netherlands Australia Thailand Research...Swiss CohortCompleted